TLCM
ARLZ
Tiger Legatus Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,985,000
| Closed | -$8.75M | – | 18 |
|
|
2016
Q4 | $8.75M | Buy |
1,985,000
+25,000
| +1% | +$110K | 3.24% | 13 |
|
|
2016
Q3 | $9.51M | Buy |
1,960,000
+460,000
| +31% | +$2.23M | 3.09% | 13 |
|
|
2016
Q2 | $4.95M | Buy |
1,500,000
+225,000
| +18% | +$743K | 1.5% | 18 |
|
|
2016
Q1 | $4.53M | Buy |
+1,275,000
| New | +$4.53M | 1.8% | 12 |
|